BioEquity Europe has become a magnet for financial and pharmaceutical company dealmakers, and is the premier venue for biopharma companies looking to attract capital and expand their business development efforts. The 2011 conference will offer an unparalleled showcase of investment opportunities at a critical time for the life sciences.
WilmerHale Partners Joe Pillman and Rüdiger Herrmann and counsel Marcus Pickel will all be featured speakers at this event.
+ 44 (0)20 7872 1000
Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.
Thank you for your interest in WilmerHale.
